| 0 |
DRUG INEFFECTIVE |
81 |
| 1 |
CHRONIC KIDNEY DISEASE |
53 |
| 2 |
DRUG EFFECT LESS THAN EXPECTED |
34 |
| 3 |
RENAL FAILURE |
27 |
| 4 |
ACUTE KIDNEY INJURY |
23 |
| 5 |
OFF LABEL USE |
22 |
| 6 |
GASTROOESOPHAGEAL REFLUX DISEASE |
15 |
| 7 |
END STAGE RENAL DISEASE |
14 |
| 8 |
EXPIRED PRODUCT ADMINISTERED |
14 |
| 9 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
14 |
| 10 |
NAUSEA |
13 |
| 11 |
INCORRECT DOSE ADMINISTERED |
12 |
| 12 |
DYSGEUSIA |
11 |
| 13 |
ABDOMINAL PAIN UPPER |
9 |
| 14 |
DIARRHOEA |
9 |
| 15 |
PRODUCT AFTER TASTE |
9 |
| 16 |
RENAL INJURY |
9 |
| 17 |
CONDITION AGGRAVATED |
8 |
| 18 |
DYSPNOEA |
8 |
| 19 |
RENAL IMPAIRMENT |
8 |
| 20 |
ANXIETY |
7 |
| 21 |
DEPRESSION |
7 |
| 22 |
HEADACHE |
7 |
| 23 |
MALAISE |
7 |
| 24 |
ABDOMINAL DISCOMFORT |
6 |
| 25 |
DIZZINESS |
6 |
| 26 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
6 |
| 27 |
REBOUND ACID HYPERSECRETION |
6 |
| 28 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
6 |
| 29 |
UNDERDOSE |
6 |
| 30 |
VOMITING |
6 |
| 31 |
DEATH |
5 |
| 32 |
FATIGUE |
5 |
| 33 |
NEPHROGENIC ANAEMIA |
5 |
| 34 |
CHEST PAIN |
4 |
| 35 |
CONSTIPATION |
4 |
| 36 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
4 |
| 37 |
DYSPEPSIA |
4 |
| 38 |
HYPERPARATHYROIDISM SECONDARY |
4 |
| 39 |
HYPERSENSITIVITY |
4 |
| 40 |
HYPERTENSION |
4 |
| 41 |
INCORRECT DRUG ADMINISTRATION DURATION |
4 |
| 42 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
4 |
| 43 |
MIGRAINE |
4 |
| 44 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
4 |
| 45 |
THERAPEUTIC RESPONSE UNEXPECTED |
4 |
| 46 |
TUBULOINTERSTITIAL NEPHRITIS |
4 |
| 47 |
ABDOMINAL DISTENSION |
3 |
| 48 |
ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING |
3 |
| 49 |
DRUG ADMINISTRATION ERROR |
3 |
| 50 |
HOSPITALISATION |
3 |
| 51 |
HYPERCHLORHYDRIA |
3 |
| 52 |
ILLNESS |
3 |
| 53 |
INSOMNIA |
3 |
| 54 |
MATERNAL EXPOSURE DURING PREGNANCY |
3 |
| 55 |
NEPHROPATHY |
3 |
| 56 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
3 |
| 57 |
RASH |
3 |
| 58 |
REACTION TO SWEETENER |
3 |
| 59 |
RENAL HAEMANGIOMA |
3 |
| 60 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
3 |
| 61 |
THROAT IRRITATION |
3 |
| 62 |
TOOTH FRACTURE |
3 |
| 63 |
ARTHRALGIA |
2 |
| 64 |
BLOOD GLUCOSE INCREASED |
2 |
| 65 |
CHILLS |
2 |
| 66 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
2 |
| 67 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 |
| 68 |
CORONARY ARTERY DISEASE |
2 |
| 69 |
DECREASED APPETITE |
2 |
| 70 |
DRUG EFFECT DECREASED |
2 |
| 71 |
DRY MOUTH |
2 |
| 72 |
FEELING ABNORMAL |
2 |
| 73 |
FLATULENCE |
2 |
| 74 |
GASTRIC CANCER |
2 |
| 75 |
GASTROINTESTINAL DISORDER |
2 |
| 76 |
HEART RATE INCREASED |
2 |
| 77 |
HYPERKALAEMIA |
2 |
| 78 |
LOSS OF CONSCIOUSNESS |
2 |
| 79 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
| 80 |
LUNG DISORDER |
2 |
| 81 |
MUSCLE SPASMS |
2 |
| 82 |
MYALGIA |
2 |
| 83 |
NEOPLASM MALIGNANT |
2 |
| 84 |
OCULAR HYPERAEMIA |
2 |
| 85 |
ORAL DISCOMFORT |
2 |
| 86 |
OROPHARYNGEAL PAIN |
2 |
| 87 |
PAIN |
2 |
| 88 |
PANCREATITIS |
2 |
| 89 |
PRODUCT DOSE OMISSION ISSUE |
2 |
| 90 |
PRODUCTIVE COUGH |
2 |
| 91 |
PRURITUS |
2 |
| 92 |
RENAL DISORDER |
2 |
| 93 |
STRESS |
2 |
| 94 |
TOOTH DISORDER |
2 |
| 95 |
TREMOR |
2 |
| 96 |
URINARY TRACT INFECTION |
2 |
| 97 |
URTICARIA |
2 |
| 98 |
WEIGHT DECREASED |
2 |
| 99 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
1 |
| 100 |
ADVERSE DRUG REACTION |
1 |
| 101 |
ADVERSE EVENT |
1 |
| 102 |
AGEUSIA |
1 |
| 103 |
AGGRESSION |
1 |
| 104 |
AMNESIA |
1 |
| 105 |
APHTHOUS STOMATITIS |
1 |
| 106 |
ASTHENIA |
1 |
| 107 |
ASTHMA |
1 |
| 108 |
BIPOLAR II DISORDER |
1 |
| 109 |
BLADDER SPASM |
1 |
| 110 |
BLOOD POTASSIUM DECREASED |
1 |
| 111 |
BLOOD PRESSURE INCREASED |
1 |
| 112 |
BODY HEIGHT DECREASED |
1 |
| 113 |
BONE PAIN |
1 |
| 114 |
BREAST CANCER |
1 |
| 115 |
BRONCHITIS |
1 |
| 116 |
BURNING SENSATION |
1 |
| 117 |
CARDIAC ARREST |
1 |
| 118 |
CARDIAC FAILURE |
1 |
| 119 |
CARDIAC FAILURE CONGESTIVE |
1 |
| 120 |
CARDIO-RESPIRATORY ARREST |
1 |
| 121 |
CARDIOPULMONARY FAILURE |
1 |
| 122 |
CEREBROVASCULAR ACCIDENT |
1 |
| 123 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
| 124 |
CONFUSIONAL STATE |
1 |
| 125 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
| 126 |
CONTUSION |
1 |
| 127 |
COUGH |
1 |
| 128 |
COVID-19 |
1 |
| 129 |
CROHN^S DISEASE |
1 |
| 130 |
CYSTIC FIBROSIS |
1 |
| 131 |
CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION |
1 |
| 132 |
DELUSION |
1 |
| 133 |
DEVICE DIFFICULT TO USE |
1 |
| 134 |
DIABETIC NEUROPATHY |
1 |
| 135 |
DISEASE RECURRENCE |
1 |
| 136 |
DRUG EFFECT INCOMPLETE |
1 |
| 137 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
| 138 |
DRY SKIN |
1 |
| 139 |
DYSSTASIA |
1 |
| 140 |
EAR DISCOMFORT |
1 |
| 141 |
ERUCTATION |
1 |
| 142 |
ESCHERICHIA INFECTION |
1 |
| 143 |
EXERCISE TOLERANCE DECREASED |
1 |
| 144 |
EXTRA DOSE ADMINISTERED |
1 |
| 145 |
EYE PAIN |
1 |
| 146 |
EYE PRURITUS |
1 |
| 147 |
FAECES DISCOLOURED |
1 |
| 148 |
FALL |
1 |
| 149 |
FEBRILE NEUTROPENIA |
1 |
| 150 |
FEELING COLD |
1 |
| 151 |
FLUSHING |
1 |
| 152 |
FOOT FRACTURE |
1 |
| 153 |
GASTRITIS |
1 |
| 154 |
GASTROENTERITIS VIRAL |
1 |
| 155 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
| 156 |
GENERALISED ANXIETY DISORDER |
1 |
| 157 |
HALLUCINATION |
1 |
| 158 |
HALLUCINATION, VISUAL |
1 |
| 159 |
HERNIA |
1 |
| 160 |
HYPOAESTHESIA |
1 |
| 161 |
ILEUS |
1 |
| 162 |
ILL-DEFINED DISORDER |
1 |
| 163 |
INABILITY TO AFFORD MEDICATION |
1 |
| 164 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
| 165 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
| 166 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
| 167 |
INFLUENZA LIKE ILLNESS |
1 |
| 168 |
INJECTION SITE BRUISING |
1 |
| 169 |
INJECTION SITE PAIN |
1 |
| 170 |
INTENTIONAL PRODUCT MISUSE |
1 |
| 171 |
JAW FRACTURE |
1 |
| 172 |
JOINT STIFFNESS |
1 |
| 173 |
JOINT SWELLING |
1 |
| 174 |
KNEE ARTHROPLASTY |
1 |
| 175 |
LABORATORY TEST ABNORMAL |
1 |
| 176 |
LARYNGOSPASM |
1 |
| 177 |
LOSS OF BLADDER SENSATION |
1 |
| 178 |
MAJOR DEPRESSION |
1 |
| 179 |
MALABSORPTION |
1 |
| 180 |
MANIA |
1 |
| 181 |
MEMORY IMPAIRMENT |
1 |
| 182 |
MOOD SWINGS |
1 |
| 183 |
MULTI-ORGAN DISORDER |
1 |
| 184 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
| 185 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
| 186 |
MUSCULOSKELETAL DISCOMFORT |
1 |
| 187 |
NASAL CONGESTION |
1 |
| 188 |
NASAL INFLAMMATION |
1 |
| 189 |
NEPHRITIS |
1 |
| 190 |
NERVOUSNESS |
1 |
| 191 |
OESOPHAGEAL MUCOSA ERYTHEMA |
1 |
| 192 |
ORAL MUCOSAL BLISTERING |
1 |
| 193 |
ORAL PAIN |
1 |
| 194 |
OROPHARYNGEAL DISCOMFORT |
1 |
| 195 |
OSTEOMYELITIS |
1 |
| 196 |
PAIN IN EXTREMITY |
1 |
| 197 |
PALPITATIONS |
1 |
| 198 |
PARANOIA |
1 |
| 199 |
PARKINSON^S DISEASE |
1 |
| 200 |
PERIPHERAL SWELLING |
1 |
| 201 |
PHLEBITIS |
1 |
| 202 |
PHOTOPHOBIA |
1 |
| 203 |
PLATELET COUNT DECREASED |
1 |
| 204 |
PNEUMONIA |
1 |
| 205 |
POOR QUALITY SLEEP |
1 |
| 206 |
PRODUCT COMPLAINT |
1 |
| 207 |
PRODUCT LABEL ISSUE |
1 |
| 208 |
PRODUCT PACKAGING ISSUE |
1 |
| 209 |
PRODUCT SIZE ISSUE |
1 |
| 210 |
PRODUCT SUBSTITUTION ISSUE |
1 |
| 211 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
| 212 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
| 213 |
PYREXIA |
1 |
| 214 |
RASH PRURITIC |
1 |
| 215 |
REACTION TO EXCIPIENT |
1 |
| 216 |
REBOUND EFFECT |
1 |
| 217 |
RECTAL HAEMORRHAGE |
1 |
| 218 |
RENAL CANCER |
1 |
| 219 |
RENAL INFARCT |
1 |
| 220 |
RENAL TUBULAR ACIDOSIS |
1 |
| 221 |
RENAL TUBULAR NECROSIS |
1 |
| 222 |
RESTLESSNESS |
1 |
| 223 |
RETCHING |
1 |
| 224 |
SCOLIOSIS |
1 |
| 225 |
SINUSITIS |
1 |
| 226 |
SKIN REACTION |
1 |
| 227 |
SKIN TIGHTNESS |
1 |
| 228 |
SLEEP DISORDER |
1 |
| 229 |
SOCIAL PROBLEM |
1 |
| 230 |
SOMNOLENCE |
1 |
| 231 |
SPHINCTER OF ODDI DYSFUNCTION |
1 |
| 232 |
SUICIDAL IDEATION |
1 |
| 233 |
SWELLING |
1 |
| 234 |
SWOLLEN TONGUE |
1 |
| 235 |
THROAT TIGHTNESS |
1 |
| 236 |
TOE AMPUTATION |
1 |
| 237 |
TOOTHACHE |
1 |
| 238 |
TYPE 2 DIABETES MELLITUS |
1 |
| 239 |
UNEVALUABLE EVENT |
1 |
| 240 |
UPPER RESPIRATORY TRACT CONGESTION |
1 |
| 241 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
| 242 |
WEIGHT ABNORMAL |
1 |
| 243 |
WHEEZING |
1 |
| 244 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
| 245 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |